JP

Etsuo Hasegawa

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Etsuo Hasegawa. Retrieved from https://idiyas.com/inventor/etsuo-hasegawa-8y4hmefi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Etsuo Hasegawa: Innovator in Macromolecular Endoplasmic Reticulum Technology

Introduction

Etsuo Hasegawa is a notable inventor based in Japan. He has made significant contributions to the field of macromolecular technology. His work primarily focuses on the development of innovative carriers for medical and industrial applications.

Latest Patents

Etsuo Hasegawa holds a patent for the invention titled "Macromolecular Endoplasmic Reticulum." This invention relates to a macromolecular endoplasmic reticulum that comprises a polymer obtained by polymerization of a mixture containing one or more polymerizable phospholipids, cholesterol, and one or more polymerizable fatty acids. The macromolecular endoplasmic reticulum, with a fixed negative surface charge, can be utilized as a carrier for medicine, enzymes, hemoglobin, and other substances in various fields.

Career Highlights

Throughout his career, Etsuo Hasegawa has worked with several companies, including collaborations with Shinji Takeoka. His innovative approach has led to advancements in the use of macromolecular structures in practical applications.

Collaborations

Etsuo Hasegawa has collaborated with notable individuals such as Shinji Takeoka and Hiroyuki Ohno. Their combined expertise has contributed to the development of groundbreaking technologies in their respective fields.

Conclusion

Etsuo Hasegawa's work in macromolecular endoplasmic reticulum technology showcases his innovative spirit and dedication to advancing medical and industrial applications. His contributions continue to influence the field and pave the way for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…